Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03422679
Title Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cellestia Biotech AG
Indications

osteosarcoma

cholangiocarcinoma

liposarcoma

anaplastic large cell lymphoma

breast cancer

adenoid cystic carcinoma

rhabdomyosarcoma

desmoid tumor

hematologic cancer

Burkitt lymphoma

colorectal cancer

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

fibrosarcoma

marginal zone B-cell lymphoma

Advanced Solid Tumor

peripheral T-cell lymphoma

glomus tumor

Therapies

CB-103

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.